Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) on Friday, soared 6.10% from the previous trading day, before settling in for the closing price of $5.9. Within the past 52 weeks, ARCT’s price has moved between $5.85 and $24.17.
Healthcare Sector giant saw their annual sales slid by -6.84% over the last five years. The company achieved an average annual earnings per share of 28.22%. With a float of $26.02 million, this company’s outstanding shares have now reached $27.23 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.42%, while institutional ownership is 84.63%.
Arcturus Therapeutics Holdings Inc (ARCT) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.11 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.49) by -0.62. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.43 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 21.27% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
Arcturus Therapeutics Holdings Inc (ARCT) is currently performing well based on its current performance indicators. A quick ratio of 7.86 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.46, a number that is poised to hit -0.79 in the next quarter and is forecasted to reach -2.74 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
Analysing the last 5-days average volume posted by the [Arcturus Therapeutics Holdings Inc, ARCT], we can find that recorded value of 1.11 million was better than the volume posted last year of 0.69 million. As of the previous 9 days, the stock’s Stochastic %D was 4.66%.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 2.24%, which indicates a significant decrease from 11.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.54 in the past 14 days, which was lower than the 1.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.03, while its 200-day Moving Average is $14.07. Now, the first resistance to watch is $6.53. This is followed by the second major resistance level at $6.81. The third major resistance level sits at $7.12. If the price goes on to break the first support level at $5.94, it is likely to go to the next support level at $5.63. Should the price break the second support level, the third support level stands at $5.35.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
Market capitalization of the company is 177.86 million based on 28,413K outstanding shares. Right now, sales total 152,310 K and income totals -80,940 K. The company made 17,150 K in profit during its latest quarter, and -13,450 K in sales during its previous quarter.
